[1]
|
Lawrence, B., Gustafsson, B.I., Chan, A., et al. (2011) The Epidemiology of Gastroenteropancreatic Neuroendocrine Tumors. Endocrinology & Metabolism Clinics of North America, 40, 1-18. https://doi.org/10.1016/j.ecl.2010.12.005
|
[2]
|
Bettini, R., Partelli, S., Boninsegna, L., et al. (2011) Tumor Size Correlates with Malignancy in Nonfunctioning Pancreatic Endocrine Tumor. Surgery, 150, 75-82. https://doi.org/10.1016/j.surg.2011.02.022
|
[3]
|
吴文铭, 陈洁, 白春梅, 依荷芭丽•迟, 杜奕奇, 冯仕庭, 霍力, 姜玉新, 李景南, 楼文晖, 罗杰, 邵成浩, 沈琳, 王峰, 王理伟, 王鸥, 王于, 吴焕文, 邢小平, 徐建明, 薛华丹, 薛玲, 杨扬, 虞先濬, 原春辉赵宏, 朱雄增, 赵玉沛. 中国胰腺神经内分泌肿瘤诊疗指南(2020) [J]. 协和医学杂志, 2021, 12(4): 460-480.
|
[4]
|
Panzuto, F., Boninsegna, L., Fazio, N., et al. (2011) Metastatic and Locally Advanced Pancreatic Endocrine Carcinomas: Analysis of Factors Associated with Disease Progression. Journal of Clinical Oncol-ogy, 29, 2372-2377.
https://doi.org/10.1200/JCO.2010.33.0688
|
[5]
|
Han, X., Zhang, C., Tang, M., et al. (2015) The Value of Serum Chromogranin A as a Predictor of Tumor Burden, Therapeutic Response, and Nomogram-Based Survival in Well-Moderate Nonfunctional Pancreatic Neuroendocrine Tumors with Liver Metastases. European Journal of Gastro-enterology & Hepatology, 27, 527-535.
https://doi.org/10.1097/MEG.0000000000000332
|
[6]
|
Pulvirenti, A., Rao, D., Mcintyre, C.A., et al. (2019) Lim-ited Role of Chromogranin A as Clinical Biomarker for Pancreatic Neuroendocrine Tumors. HPB (Oxford), 21, 612-618. https://doi.org/10.1016/j.hpb.2018.09.016
|
[7]
|
夏艳艳, 沈瀚, 许红攀, 李智洋. 液体活检技术在肿瘤诊断中的最新研究进展[J]. 现代检验医学杂志, 2021, 36(3): 157-160.
|
[8]
|
邢加彰, 程月鹃, 白春梅. NETest液体活检技术在神经内分泌瘤诊疗领域研究进展[J]. 中国肿瘤, 2021, 30(10): 789-793.
|
[9]
|
Modlin, I.M., Kidd, M., Falconi, M., et al. (2021) A Multigenomic Liquid Biopsy Biomarker for Neuroendocrine Tumor Disease Outperforms CgA and Has Surgical and Clinical Utility. Annals of Oncology, 32, 1425-1433.
https://doi.org/10.1016/j.annonc.2021.08.1746
|
[10]
|
Öberg, K., Califano, A., Strosberg, J.R., et al. (2020) A Me-ta-Analysis of the Accuracy of a Neuroendocrine Tumor mRNA Genomic Biomarker (NETest) in Blood. Annals of On-cology, 31, 202-212.
https://doi.org/10.1016/j.annonc.2019.11.003
|
[11]
|
Lambin, P., Rios-Velazquez, E., Leijenaar, R., et al. (2012) Ra-diomics: Extracting More Information from Medical Images Using Advanced Feature Analysis. European Journal of Cancer, 48, 441-446.
https://doi.org/10.1016/j.ejca.2011.11.036
|
[12]
|
Litvin, A.A., Burkin, D.A., Kropinov, A.A. and Paramzin, F.N. (2021) Radiomics and Digital Image Texture Analysis in Oncology (Review). Sovremennye Tehnologii v Medicine, 13, 97-104. https://doi.org/10.17691/stm2021.13.2.11
|
[13]
|
覃山羽. 超声内镜在胰腺神经内分泌肿瘤诊治中的新进展[J]. 中华消化内镜杂志, 2022, 39(8): 611-615.
|
[14]
|
Khashab, M.A., Yong, E., Lennon, A.M., et al. (2011) EUS Is Still Superior to Multidetector Computerized Tomography for Detection of Pancreatic Neuroendocrine Tumors. Gas-trointestinal Endoscopy, 73, 691-696.
https://doi.org/10.1016/j.gie.2010.08.030
|
[15]
|
Puli, S.R., Kalva, N., Bechtold, M.L., et al. (2013) Diagnostic Ac-curacy of Endoscopic Ultrasound in Pancreatic Neuroendocrine Tumors: A Systematic Review and Meta-Analysis. World Journal of Gastroenterology, 19, 3678-3684.
https://doi.org/10.3748/wjg.v19.i23.3678
|
[16]
|
Palazzo, M., Napoléon, B., Gincul, R., et al. (2018) Contrast Har-monic EUS for the Prediction of Pancreatic Neuroendocrine Tumor Aggressiveness (with Videos). Gastrointestinal En-doscopy, 87, 1481-1488.
https://doi.org/10.1016/j.gie.2017.12.033
|
[17]
|
Chen, K., Zhang, W., Zhang, Z., et al. (2018) Simple Vascular Ar-chitecture Classification in Predicting Pancreatic Neuroendocrine Tumor Grade and Prognosis. Digestive Diseases and Sciences, 63, 3147-3152.
https://doi.org/10.1007/s10620-018-5240-z
|
[18]
|
杨甜甜. 胰腺神经内分泌肿瘤的CT表现与病理分级的相关性研究[D]: [硕士学位论文]. 济南: 济南大学, 2017.
|
[19]
|
韩滨泽, 纪元, 曾蒙苏, 王明亮. 胰腺神经内分泌肿瘤计算机断层扫描增强特征对术前病理分级的预测价值[J]. 中华消化杂志, 2021, 41(9): 613-618.
|
[20]
|
Canellas, R., Burk, K.S., Parakh, A. and Sahani, D.V. (2018) Prediction of Pancreatic Neuroendocrine Tumor Grade Based on CT Features and Texture Analysis. AJR American Journal of Roentgenology, 210, 341-346.
https://doi.org/10.2214/AJR.17.18417
|
[21]
|
代博, 王梅云, 闫峰山, 贺慧, 窦社伟, 张孝先, 谭红娜. MRI在G1/G2胰腺神经内分泌肿瘤病理分级及临床分期中的价值[J]. 放射学实践, 2022, 37(1): 72-78. https://doi.org/10.13609/j.cnki.1000-0313.2022.01.013
|
[22]
|
Jang, K.M., Kim, S.H., Lee, S.J. and Choi, D. (2014) The Value of Gadoxetic Acid-Enhanced and Diffusion-Weighted MRI for Prediction of Grading of Pancreatic Neuroen-docrine Tumors. Acta Radiologica, 55, 140-148.
https://doi.org/10.1177/0284185113494982
|
[23]
|
Liu, C., Bian, Y., Meng, Y., et al. (2022) Preoperative Prediction of G1 and G2/3 Grades in Patients with Nonfunctional Pancreatic Neuroendocrine Tumors Using Multimodality Imaging. Academic Radiology, 29, e49-e60.
https://doi.org/10.1016/j.acra.2021.05.017
|
[24]
|
Bian, Y., Li, J., Cao, K., et al. (2021) Magnetic Resonance Imaging Radiomic Analysis Can Preoperatively Predict G1 and G2/3 Grades in Patients with NF-pNETs. Abdominal Radiology (NY), 46, 667-680.
https://doi.org/10.1007/s00261-020-02706-0
|
[25]
|
Treglia, G., Castaldi, P., Rindi, G., Giordano, A. and Rufini, V. (2012) Diagnostic Performance of Gallium-68 Somatostatin Receptor PET and PET/CT in Patients with Thoracic and Gastroenteropancreatic Neuroendocrine Tumours: A Meta-Analysis. Endocrine, 42, 80-87. https://doi.org/10.1007/s12020-012-9631-1
|
[26]
|
Niederle, B., Pape, U.F., Costa, F., et al. (2016) Vienna Consen-sus Conference Participants. ENETS Consensus Guidelines Update for Neuroendocrine Neoplasms of the Jejunum and Ileum. Neuroendocrinology, 103, 125-138.
https://doi.org/10.1159/000443170
|
[27]
|
Rinzivillo, M., Partelli, S., Prosperi, D., et al. (2018) Clinical Usefulness of 18F-Fluorodeoxyglucose Positron Emission Tomography in the Diagnostic Algorithm of Advanced Entero-Pancreatic Neuroendocrine Neoplasms. Oncologist, 23, 186-192. https://doi.org/10.1634/theoncologist.2017-0278
|
[28]
|
Mapelli, P., Partelli, S., Salgarello, M., et al. (2020) Dual Tracer 68Ga-DOTATOC and 18F-FDG PET/Computed Tomography Radiomics in Pancreatic Neuroendocrine Neo-plasms: An Endearing Tool for Preoperative Risk Assessment. Nuclear Medicine Communications, 41, 896-905. https://doi.org/10.1097/MNM.0000000000001236
|
[29]
|
Zhou, J., Zhao, R., Pan, Y., et al. (2022) The Diagnostic and Grading Accuracy of 68Ga-DOTATATE and 18F-FDG PET/MR for Pancreatic Neuroendocrine Neoplasms. Fron-tiers in Oncology, 12, Article ID: 796391.
https://doi.org/10.3389/fonc.2022.796391
|